Article in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Emmanuela Adjei-SowahDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Sarea Y Recalde PhillipsDepartment of Bioengineering, Phil and Penny Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR, USA.
Alayna E LoiselleDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Danielle S W BenoitDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Funding
Tissue Engineering Strategies to Revitalize Bone AllograftsR01AR064200 · NIAMS · UNIVERSITY OF ROCHESTER · PI Danielle S. Benoit · 2013 to 2026
$4.0M
Engineered salivary gland tissue chips (Administrative Supplement)UH3DE027695 · NIDCR · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., DELOUISE, LISA A · 2019 to 2021
$3.0M
Modulating Cell-fate to Promote Regenerative Tendon HealingR01AR077527 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2021 to 2025
$2.0M
s100a4 Signaling in Fibrotic Diabetic Tendon HealingR01AR073169 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2018 to 2022
$1.7M
Bone-targeted polymer therapeutics for nonunion fracture healingR21AG072692 · NIA · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S. · 2022 to 2023
$406k
Tendon TRAP: Targeted Therapeutic Delivery to Enhance Tendon HealingR21AR081063 · NIAMS · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., LOISELLE, ALAYNA · 2022 to 2023
$373k
Molecular Multispectral ImagingS10RR026542 · NCRR · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A · 2010 to 2010
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Advancing tendon healing through nanoparticle-based drug delivery systems. · full record | OpenQuestion